Search

Aims: To explore the prevalence of Intimate Partner Violence (IPV) and its association with sociodemographic factors, symptoms of depression, perceived need for mental care and primary health care utilization. Another aim was to explore the prevalence of suicidal ideation and attempts over a 26 year period and associations between sociodemographic factors and lifetime suicidal ideation. Method: Two postal surveys and face-to- face interviews. Prevalence’s were used in descriptive data. Crude and adjusted Odds Ratios with 95% Confidence Intervals were used in bivariable and multivariable logistic regression analyses. Results: Compared to men, women reported higher prevalence of sexual violence for past year and earlier life. For past year, 11.0% of the men and 8.0% of the women reported exposure to physical violence, whereas 15% of the women and 11.0% of the men reported such violence for earlier in life (Study I). Being single and having poor social support was associated with lifetime exposure to physical and/or sexual IPV among women, whereas among men, a relationship of ≤ 3 years was associated with IPV (Study I). Being exposed to physical, sexual violence as well as isolating control during past year, was associated with self-reported symptoms of depression among women (Study II). Women exposed to physical IPV past 5 years were three times more likely to perceive the need for mental health care as compared to unexposed women (Study III). Of the women aged 20-30 years, 45% reported lifetime suicidal ideation in 2013/15 compared to 1989/91 when 33% reported this. Self-reported rates of attempted suicide remained similar. Among women aged 31-49 years, 35.4% reported lifetime suicidal ideation in 2013/15 compared to 2000/02 when 23.1% reported this. In this age group, lifetime suicide attempts increased from 0.0% in 2000/02 to 3.6% in 2013/15. Having compulsory and/ or high school education, being unemployed, being a student and being single was associated with lifetime suicidal ideation (Study IV). Conclusions: Both women and men were exposed to IPV, however, the exposure showed different patterns between men and women. IPV was associated with symptoms of depression and need for mental care among women. Current finding indicate an increasing trend in suicidal ideation and attempts which should be further explored in future studies.

Background: Anxiety disorders are a major cause of burden of disease. Treatment gaps have been described, but a worldwide evaluation is lacking. We estimated, among individuals with a 12‐month DSM‐IV (where DSM is Diagnostic Statistical Manual) anxiety disorder in 21 countries, the proportion who (i) perceived a need for treatment; (ii) received any treatment; and (iii) received possibly adequate treatment. Methods: Data from 23 community surveys in 21 countries of the World Mental Health (WMH) surveys. DSM‐IV mental disorders were assessed (WHO Composite International Diagnostic Interview, CIDI 3.0). DSM‐IV included posttraumatic stress disorder among anxiety disorders, while it is not considered so in the DSM‐5. We asked if, in the previous 12 months, respondents felt they needed professional treatment and if they obtained professional treatment (specialized/general medical, complementary alternative medical, or nonmedical professional) for “problems with emotions, nerves, mental health, or use of alcohol or drugs.” Possibly adequate treatment was defined as receiving pharmacotherapy (1+ months of medication and 4+ visits to a medical doctor) or psychotherapy, complementary alternative medicine or nonmedical care (8+ visits). Results: Of 51,547 respondents (response = 71.3%), 9.8% had a 12‐month DSM‐IV anxiety disorder, 27.6% of whom received any treatment, and only 9.8% received possibly adequate treatment. Of those with 12‐month anxiety only 41.3% perceived a need for care. Lower treatment levels were found for lower income countries. Conclusions: Low levels of service use and a high proportion of those receiving services not meeting adequacy standards for anxiety disorders exist worldwide. Results suggest the need for improving recognition of anxiety disorders and the quality of treatment. The U.S. National Comorbidity Survey Replication (NCS‐R) is supported by the National Institute of Mental Health (NIMH; U01‐MH60220) with supplemental support from the National Institute of Drug Abuse (NIDA), the Substance Abuse and Mental Health Services Administration (SAMHSA). SEL (Sara Evans‐Lacko) currently holds a Starting Grant from the European Research Council (337673). The Robert Wood Johnson Foundation (RWJF; Grant 044708), and the John W. Alden Trust. Dr. Thornicroft is supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South London at King's College London Foundation Trust. Dr. Thornicroft acknowledges support from the following: the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South London at King's College London Foundation Trust; the Department of Health via the National Institute for Health Research (NIHR) Biomedical Research Centre and Dementia Unit awarded to South London and Maudsley NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust; the European Union Seventh Framework Programme (FP7/2007‐2013) Emerald project.